In addition, our bulk/single-cell integration applied to a PD1-treated gastric cancer cohort identified gene programs expressed in CD8+ T cells and activated fibroblasts of the TME that contrastingly influenced the outcome of immunotherapy response. This evidence concerns the gene CD8A and gastric cancer.